Know Cancer

or
forgot password

Identifying Prostate Brachytherapy Seeds Using MRI


N/A
18 Years
N/A
Open (Enrolling)
Male
Prostate Cancer Patients Who Have Brachytherapy Seed Implant

Thank you

Trial Information

Identifying Prostate Brachytherapy Seeds Using MRI


Inclusion Criteria:



1. At least 18 years old

2. Histologic diagnosis of adenocarcinoma of the prostate

3. No contraindications for Pelvic body MRI

4. Patients undergoing LDR brachytherapy at PMH and scheduled for post implant analysis
with CT-MR (standard at PMH)

5. Ability to provide written informed consent to participate in the study

Exclusion Criteria:

1. Contraindication for Pelvic body MRI

2. Patient not willing/consenting for this study

Type of Study:

Interventional

Study Design:

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Determine if using the MR scan -(SWI) used to detect the implanted radioactive seeds will reduce registration errors

Outcome Time Frame:

6 months

Safety Issue:

No

Principal Investigator

Saibishkumar Elantholiparameswaran, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University Health Network, The Princess Margaret

Authority:

Canada: Review Ethics Committee

Study ID:

UHN REB 12-5302-CE

NCT ID:

NCT01878058

Start Date:

October 2012

Completion Date:

September 2013

Related Keywords:

  • Prostate Cancer Patients Who Have Brachytherapy Seed Implant
  • Prostate cancer
  • Brachytherapy
  • Seed implant
  • Prostatic Neoplasms

Name

Location